The Faculty of Medicine, Prince of Songkla University is the sixth oldest medical school in Thailand located in Hat Yai District, Songkhla Province and is the fourth oldest faculty of Prince of Songkla University, opening in 1972 by royal decree.

During the past decade, Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine, Prince of Songkla University conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 1 clinical trials were completed, i.e. on average, 7.1% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine, Prince of Songkla University" #1 collaborator was "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Prince of Songkla University" with 2 trials as a collaborator, "Clinixir Co., Ltd." with 1 trials as a collaborator, "McGill University Health Centre/Research Institute of the McGill University Health Centre" with 1 trials as a collaborator and "Program Management Unit-C (PMU-C), governed by Ministry of Higher Education, Science, Research and Innovation (MHESI)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine, Prince of Songkla University" are "COVID-19" (2 trials), "Acinetobacter Infections" (1 trials), "Agitation" (1 trials), "Anesthesia; Adverse Effect" (1 trials) and "Autoimmune Diseases" (1 trials). Many other conditions were trialed in "Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine, Prince of Songkla University" in a lesser frequency.

Most popular intervention types in "Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine, Prince of Songkla University" are "Drug" (16 trials), "Other" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Imipenem" (4 trials), "Placebo" (3 trials), "PF-07321332" (2 trials), "Ritonavir" (2 trials) and "AstraZeneca ChAdOx1 AZD1222 vaccine (AZ) full dose" (1 trials). Other intervention names were less common.

The vast majority of trials in "Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine, Prince of Songkla University" are 23 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine, Prince of Songkla University". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine, Prince of Songkla University, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine, Prince of Songkla University, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 2 trials that are defined as “Not Applicable".